High cure rates for HCV genotype 6 in advanced liver fibrosis with 12 weeks sofosbuvir and daclatasvir: The Vietnam SEARCH Study

High cure rates for HCV genotype 6 in advanced liver fibrosis with 12 weeks sofosbuvir and daclatasvir: The Vietnam SEARCH Study

Background Genotype 6 is the most genetically diverse lineage of hepatitis C virus (HCV), and predominates in Vietnam. It can be treated with sofosbuvir with daclatasvir (SOF/DCV), the lowest costing treatment combination globally. In regional guidelines, longer treatment durations of SOF/DCV (24 we...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Flower, B, McCabe, L, Ngoc, CL, Hung, LM, Phuong, LT, Trong, TD, Thi, TV, Kim, HVT, Tat, TN, Hong, DPT, Chau, ANT, Thi, TD, Tuyet, NTT, Tarning, J, Kingsley, C, Kestelyn, E, Pett, SL, Thwaites, G, Chau, NVV, Smith, D, Barnes, E, Ansair, A, Turner, H, Rahman, M, Walker, AS, Day, J, Cooke, GS
التنسيق: Journal article
اللغة:English
منشور في: Oxford University Press 2021

مواد مشابهة

مواد مشابهة